Versant Ventures IV LLC 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 07:33 am Purchase |
2020-09-29 | 13D | CRISPR Therapeutics AG CRSP |
Versant Ventures IV LLC | 1,344,010 1.900% |
1,344,010 (New Position) |
Filing |